Mostrar el registro sencillo del ítem

dc.contributor.authorRodríguez Cabello, José Carlos 
dc.contributor.authorPiña, María Jesús
dc.contributor.authorIbáñez Fonseca, Arturo
dc.contributor.authorFernández Colino, Alicia
dc.contributor.authorArias Vallejo, Francisco Javier 
dc.date.accessioned2017-12-12T18:36:35Z
dc.date.available2017-12-12T18:36:35Z
dc.date.issued2015
dc.identifier.citationBioconjugate Chemistry, 2015, 26 (7), p. 1252–1265es
dc.identifier.issn1043-1802es
dc.identifier.urihttp://uvadoc.uva.es/handle/10324/27585
dc.descriptionProducción Científicaes
dc.description.abstractThis Review discusses the use of elastin-like polymers and their recombinant version, elastin-like recombinamers, in drug-delivery systems. These macromolecules exhibit a number of interesting properties that are rarely found together in any other family of materials, especially extremely high biocompatibility, high bioactivity and functionality, complex yet fully controlled composition, and stimuli responsiveness. Appropriate design of these molecules opens up a broad range of different possibilities for their use in new therapeutic platforms. The first of these described herein is the use of ELRs in single-molecule devices as therapeutic entities in their own right. Subsequently, we describe how the self-assembly properties of these materials can be exploited to create nanocarriers and, eventually, microcarriers that are able to temporally and spatially control and direct the release of their drug load. Intracellular drug-delivery devices and nanocarriers for treating cancer are among the uses described in that section. Finally, the use of ELRs as base materials for implantable drug depots, in the form of hydrogels, is discussed.es
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherAmerican Chemical Societyes
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.classificationFármacoses
dc.subject.classificationElastinaes
dc.titleNanotechnological Approaches to Therapeutic Delivery Using Elastin-Like Recombinamerses
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doi10.1021/acs.bioconjchem.5b00183es
dc.relation.publisherversionhttp://pubs.acs.org/doi/abs/10.1021/acs.bioconjchem.5b00183es
dc.peerreviewedSIes
dc.description.projectMinisterio de Industria, Economía y Competitividad (proyectos PRI-PIBAR-2011–1403, MAT2012–38043, MAT2013–42473-R y MAT2013–41723-R)es
dc.description.projectJunta de Castilla y León (programa de apoyo a proyectos de investigación – Ref. VA152A12, VA155A12 y VA313U14)es
dc.description.projectCIBER-BBN, y la Junta de Castilla y León y el Instituto de Salud Carlos III mediante el "Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León"es
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem